menu
    • menu

    Company profile for MavriX Bio

    NEW Drugs in Dev: 1
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MavriX Bio, launched in 2024 through FAST’s AS²Bio accelerator, is a biotechnology company focused exclusively on Angelman syndrome. Built on pioneering research from Dr. Jim Wilson’s lab at the University of Pennsylvania (now GEMMABio), MavriX aims to advance the first investigational gene replacement therapy for this rare neurogenetic disorder. With strong leadership and strategic guidance from AS²Bio, MavriX is commit...
    MavriX Bio, launched in 2024 through FAST’s AS²Bio accelerator, is a biotechnology company focused exclusively on Angelman syndrome. Built on pioneering research from Dr. Jim Wilson’s lab at the University of Pennsylvania (now GEMMABio), MavriX aims to advance the first investigational gene replacement therapy for this rare neurogenetic disorder. With strong leadership and strategic guidance from AS²Bio, MavriX is committed to translating scientific innovation into meaningful clinical progress.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MavriX BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1875 South Grant Street · Suite 700 · San Mateo
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mvxbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mavrix Bio Initiates ASCEND-AS Trial For MVX-220, Gene Therapy
    Mavrix Bio Initiates ASCEND-AS Trial For MVX-220, Gene Therapy

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mavrix-bio-announces-first-patient-dosed-in-ascend-as-trial-of-mvx-220-investigational-gene-therapy-for-angelman-syndrome-302607143.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Mavrix Bio Gets FDA Fast Track For Mvx-220 In Angelman Syndrome
    Mavrix Bio Gets FDA Fast Track For Mvx-220 In Angelman Syndrome

    22 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mavrix-bio-receives-fda-fast-track-designation-for-mvx-220-for-treatment-of-angelman-syndrome-302562593.html

    PR NEWSWIRE
    22 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search